Agilent | A - Operating Expenses

Stock Price
115.00
Daily Change
-0.48 -0.42%
Monthly
-1.41%
Yearly
11.01%
Q2 Forecast
112.00

Agilent reported $1.44B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
Agilent USD 1.44B 27M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Henry Schein USD 3.25B 110M Dec/2025
Hologic USD 349.4M 447.1M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 2B 263.6M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.42B 4.84B Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 661.85M 1.67B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025